SCHEMBL9045459

SCHEMBL9045459

O=S(=O)(Nc1ncnc(Cl)c1Cc1cccc2ccccc12)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
HTR1A P08908 1/20 0.45
HTR2A P28223 1/20 0.45
HTR7 P34969 1/20 0.45
HTR6 P50406 1/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SLC40A1 Q9NP59 1/20 0.42
EDNRA P25101 2/20 0.42
EDNRB P24530 1/20 0.42
ALOX12 P18054 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CDC25A P30304 1/20 0.40
CDC25B P30305 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9045435 0.84 EDNRA (0.60) ALDH1A1POLBHTR1AHTR2AHTR7
SCHEMBL9044490 0.82 EDNRA (0.45) ALDH1A1POLBMEN1KMT2AEDNRA
SCHEMBL9045980 0.80 MEN1 (0.47) ALDH1A1POLBMEN1KMT2AEDNRA
SCHEMBL9046333 0.78 MAPT (0.45) ALDH1A1MEN1KMT2ASLC40A1EDNRA
SCHEMBL9047889 0.77 ADRA2A (0.46) ALDH1A1HTR1ALMNAKDM4E
SCHEMBL9047760 0.76 EDNRA (0.42) ALDH1A1POLBHTR6MEN1KMT2A
SCHEMBL9045300 0.74 EDNRA (0.58) ALDH1A1POLBMEN1KMT2AEDNRA
SCHEMBL9048076 0.74 KDM4E (0.49) ALDH1A1POLBMEN1KMT2AEDNRA
SCHEMBL9047103 0.73 EDNRA (0.56) ALDH1A1MEN1KMT2AEDNRAEDNRB
SCHEMBL9046239 0.73 EDNRA (0.40) ALDH1A1POLBMEN1KMT2AEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
EP-0691962-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1996-01-17 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed